← Nazad


Pozo F



Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15-64-year-olds in Europe: exploration by birth cohort. Euro Surveill. 2019;24(48).

Autori: Kissling E, Pozo F, Buda S, Vilcu A, Gherasim A, Brytting M, et al.
Godina: 2019

Effectiveness of influenza vaccine against influenza A in Europe in seasons of different A(H1N1)pdm09 and the same A(H3N2) vaccine components (2016–17 and 2017–18). Vaccine X. 2019;Dec 10;3:100042.

Autori: Kissling E, Pozo F, Buda S, Vilcu A, Rizzo C, Gherasim A, et al.
Godina: 2019

Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019. Euro Surveill. 2019;24(8):2-14.

Autori: Kissling E, Rose A, Emborg H-D, Gherasim A, Pebody R, Pozo F, et al.
Godina: 2019

2015/16 I-MOVE/I-MOVE+ multicentre case control study in Europe: moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage mismatched influenza B among children. Influenza Other Respir Viruses. 2017 Nov 10. doi: 10.1111/irv.12520. [Epub ahead of print]

Autori: Kissling E, Valenciano M, Pozo F, Vilcu AM, Reuss A, Rizzo C, Larrauri A, Horváth JK, Brytting M, Domegan L, Korczyńska M, Meijer A, Machado A, Ivanciuc A, Višekruna Vučina V, van der Werf S, Schweiger B, Bella A, Gherasim A, Ferenczi A, Zakikhany K, O Donnell J, Paradowska-Stankiewicz I, Dijkstra F, Guiomar R, Lazar M, Kurečić Filipović S, Johansen K, Moren A, I-MOVE/I-MOVE+ study team
Godina: 2017